ID   PC-8
AC   CVCL_4Z01
SY   PC 8
DR   ChEMBL-Cells; CHEMBL3307866
DR   ChEMBL-Targets; CHEMBL614101
DR   PubChem_Cell_line; CVCL_4Z01
DR   Wikidata; Q54938467
RX   PubMed=758928;
RX   PubMed=1367039;
RX   PubMed=3902783;
CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
RX   PubMed=758928; DOI=10.1038/bjc.1979.3; PMCID=PMC2009802;
RA   Kinjo M., Oka K., Naito S., Kohga S., Tanaka K., Oboshi S., Hayata Y.,
RA   Yasumoto K.;
RT   "Thromboplastic and fibrinolytic activities of cultured human cancer
RT   cell lines.";
RL   Br. J. Cancer 39:15-23(1979).
//
RX   PubMed=1367039; DOI=10.1007/BF00365092;
RA   Shinmoto H., Dosako S., Yamada K., Shirahata S., Murakami H.;
RT   "Purification and some properties of proliferation suppressing factor
RT   from human lung adenocarcinoma PC-8.";
RL   Cytotechnology 4:121-126(1990).
//
RX   PubMed=3902783; DOI=10.1007/BF02620891;
RA   Murakami H., Hashizume S., Ohashi H., Shinohara K., Yasumoto K.,
RA   Nomoto K., Omura H.;
RT   "Human-human hybridomas secreting antibodies specific to human lung
RT   carcinoma.";
RL   In Vitro Cell. Dev. Biol. 21:593-596(1985).
//